Under Evaluation
English Title: Chinese and Foreign Clinical Medicine
ISSN (Print): 3080-7611
ISSN (Online): 3080-762X
CODEN: ZLYABX(International Standard Serial Identifier, a globally unique identifier assigned by the Chemical Abstracts Service (CAS), USA)
Publication Model: Gold Open Access (Gold OA), licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), with permanent free full-text access
Publisher: Quest Press Limited
Languages of Publication: Chinese, English
Publication Frequency: Bimonthly
Subject Category: Clinical Medicine and Translational Research
Submission Language: Chinese (English title, abstract, keywords, author names and affiliations required)
Distribution Support: China International Book Trading Corporation (CIBTC)
Import Registration Number: G015Z110
The journal is indexed by numerous authoritative academic databases worldwide. It is committed to promoting the global dissemination of high-quality research and collaborating with scholars across the globe to build an open, collaborative and forward-looking international academic community.
This journal is positioned as “a bridge for clinical medicine research connecting China and the world”.Its core features are clinical practicability, international cutting-edge orientation and evidence-based innovation.We emphasize clinical problem-oriented research design, focus on the translation and application of research results into clinical practice, commit to promoting the optimization of evidence-based diagnosis and treatment programs, and facilitate in-depth exchanges and mutual learning of clinical research methods and achievements between China and abroad.
Chinese and Foreign Clinical Medicine is an international academic journal focusing on difficult clinical problems and cutting-edge medical advances.The journal is dedicated to publishing original research, evidence-based medical evaluations and technological innovations with clear clinical guiding value, covering key fields such as disease diagnosis, treatment optimization, prognosis evaluation and medical quality improvement.It aims to provide a high-level academic exchange platform for clinicians, researchers and medical administrators, and promote the globalization and precision development of clinical medicine.
The journal sincerely invites original research and practical papers in the following fields (including but not limited to):
Innovation in Disease Diagnosis and Treatment: Analysis of difficult cases, optimization of diagnostic criteria, innovative treatment pathways, individualized treatment regimens
Clinical Translational Research: Validation of biomarkers, exploration of targeted therapy, clinical evaluation of medical technology, innovative application of medical devices
Evidence-Based Medical Practice: Systematic review/Meta-analysis, clinical guideline development, real-world research, medical decision optimization
Medical Quality and Safety: Patient safety system, medical quality control indicators, clinical pathway management, adverse event prevention
Interdisciplinary Application: AI-assisted diagnosis, digital medical technology, precision medicine practice, multidisciplinary collaboration model
Global Health Research: Comparative study of disease spectrum, comparison of medical systems, cross-border medical cooperation, progress in diagnosis and treatment of rare diseases
Medical Education and Humanities: Clinical ability training, medical simulation teaching, doctor-patient communication research, medical ethics discussion
Submissions must be original and unpublished clinical research.The research design must comply with ethical requirements, with authentic and complete data, appropriate statistical analysis, and conclusions with clear guiding significance for clinical practice.The journal implements a strict double-blind peer review system.
The full text must be written in Chinese.
Article title
Author names and affiliations; brief introduction of the first author (clinical specialty, contact information)
Structured abstracts (Purpose, Methods, Results, Conclusions)
3–5 keywords (MeSH terms recommended)
Ethical statement: Approval number of ethical review required for studies involving human or animal experiments
The vision of the journal is to become an authoritative academic platform connecting China and the world in the field of clinical medicine.We are committed to promoting evidence-based innovation in clinical practice, facilitating the sharing and integration of high-quality global medical resources, and ultimately serving to improve the quality of medical services and patient health outcomes by disseminating scientific research with direct clinical value.
The journal strictly adopts the Gold Open Access model. All published articles are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).Articles are permanently and freely available immediately upon publication, allowing clinicians and researchers to use the content for legal non-commercial purposes, provided that the original authors and source are properly cited.License details: https://creativecommons.org/licenses/by/4.0/
| VOLUME | ISSUE | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|